Daclahep comprises Daclatasvir as an active substance and it belongs to a group of medications known as antiviral agents. Daclahep (Daclatasvir) is available in the strength of 60 mg in the form of tablets for oral use only by Hetero Drugs Ltd. This tablet is prescribed for the treatment of chronic (long-lasting) hepatitis C virus (HCV) infection and it works by boosting the immune system to fight against the infection. Daclahep also prevents the action of a protein that helps in stopping the progression of the virus. Do not perform any activity that requires mental alertness in order to avoid severe side effects, during therapy with Daclahep tablets.